Promoting tau secretion and propagation by hyperactive p300/CBP via autophagy-lysosomal pathway in tauopathy | Molecular Neurodegeneration | Full Text
Tau Secretion and Propagation Is Regulated by p300/CBP via Autophagy-Lysosomal Pathway in Tauopathy | bioRxiv
Physiological degradation of tau. Tau is degraded by both the... | Download Scientific Diagram
IJMS | Free Full-Text | Autophagy and Tau Protein
Pimozide reduces toxic forms of tau in TauC3 mice via 5′ adenosine monophosphate‐activated protein kinase‐mediated autophagy - Kim - 2017 - Journal of Neurochemistry - Wiley Online Library
Cells | Free Full-Text | Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease
Phenotypic Discovery of Neuroprotective Agents by Regulation of Tau Proteostasis via Stress‐Responsive Activation of PERK Signaling - Shin - 2021 - Angewandte Chemie International Edition - Wiley Online Library
Alzheimer disease-related disruption of tau degradation. Impairment of... | Download Scientific Diagram
Celastrol enhances transcription factor EB (TFEB)-mediated autophagy and mitigates Tau pathology: Implications for Alzheimer's disease therapy - ScienceDirect
IJMS | Free Full-Text | Autophagy in Neurodegenerative Diseases: A Hunter for Aggregates
The degradation of tau proteins. Tau can be targeted by both the UPS... | Download Scientific Diagram
IJMS | Free Full-Text | Autophagy and Tau Protein
Tau Accumulation and Defective Autophagy: A Common Pathological Mechanism Underlying Repeat-Expansion-Induced Neurodegenerative Diseases? | SpringerLink
A possible feed-forward cycle between pathological tau species and... | Download Scientific Diagram
Figure 2 | Autophagy at synapses in neurodegenerative diseases | SpringerLink
A Tauopathy-Homing and Autophagy-Activating Nanoassembly for Specific Clearance of Pathogenic Tau in Alzheimer's Disease | ACS Nano
PDF] Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease | Semantic Scholar
Frontiers | Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
Figure 2 Autophagy in neurological diseases
Frontiers | Targeting Autophagy for the Treatment of Alzheimer's Disease: Challenges and Opportunities
TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy | Science Advances
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
model of fragmentation and degradation of tau RD ∆K by the... | Download Scientific Diagram
Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation